Tag: Alzheimer’s

Biomarkers for the Identification and Treatment of Dementia

| February 25, 2008 | 0 Comments

by Steven D. Targum, MD Dr. Targum is an executive-in-residence at Oxford BioScience Partners and on the faculty of the Department of Psychiatry at the Massachusetts General Hospital. Dr. Targum is chief medical officer at BrainCells Inc., and chief medical advisor to Prana Biotechnology Ltd. Dr. Targum is on the editorial staff of Psychiatry 2008.

Continue Reading

Alzheimer’s Therapies

| August 5, 2007 | 0 Comments

by Elisa F. Cascade; Amir H. Kalali, MD; and Edmund Howe, MD, JD Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Howe is […]

Continue Reading

Initial Screening of Patients for Alzheimer’s Disease and Minimal Cognitive Impairment

| July 3, 2007 | 0 Comments

by Edmund Howe, MD, JD Dr. Howe is Professor, Department of Psychiatry, and Director, Programs in Medical Ethics, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Continue Reading